{"log_id": 146387251488274821, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.008397, "average": 0.945639, "min": 0.742433}, "location": {"width": 119, "top": 148, "height": 26, "left": 185}, "words": "【用法用量】"}, {"probability": {"variance": 1e-06, "average": 0.99901, "min": 0.997733}, "location": {"width": 90, "top": 204, "height": 26, "left": 180}, "words": "推荐剂量"}, {"probability": {"variance": 0.007643, "average": 0.968258, "min": 0.425551}, "location": {"width": 826, "top": 247, "height": 31, "left": 224}, "words": "本品推荐剂量为1000mg(4x250mg片口服每日一次,与泼尼松5mg口服每日2次联"}, {"probability": {"variance": 0.002292, "average": 0.982929, "min": 0.749523}, "location": {"width": 856, "top": 295, "height": 29, "left": 180}, "words": "用。本品须空腹服用,与食物同时服用会增加本品的全身暴露量,在服用本品之前至少2小时"}, {"probability": {"variance": 0.004548, "average": 0.968505, "min": 0.695037}, "location": {"width": 870, "top": 344, "height": 28, "left": 181}, "words": "和服用本品之后至少1小时内不得进食(见药代动力学)。本品应当伴水整片吞服。请勿掰碎或"}, {"probability": {"variance": 0.02859, "average": 0.898542, "min": 0.605699}, "location": {"width": 88, "top": 391, "height": 26, "left": 182}, "words": "咀嚼服用"}, {"probability": {"variance": 0.001707, "average": 0.962466, "min": 0.876899}, "location": {"width": 175, "top": 486, "height": 27, "left": 182}, "words": "用药期间毒性监测"}, {"probability": {"variance": 0.007657, "average": 0.974356, "min": 0.607729}, "location": {"width": 826, "top": 529, "height": 31, "left": 224}, "words": "在开始使用本品治疗之前,应当检测血清转氨酶;并在接受治疗的前3个月每两周检测一"}, {"probability": {"variance": 0.003117, "average": 0.982535, "min": 0.665814}, "location": {"width": 873, "top": 576, "height": 29, "left": 182}, "words": "次,此后每个月检测一次。对血压、血清钾和体液潴留应当每月监测一次。但对于存在充血性"}, {"probability": {"variance": 0.004367, "average": 0.979044, "min": 0.645243}, "location": {"width": 827, "top": 624, "height": 28, "left": 186}, "words": "心力衰竭重大风险的患者,应在接受治疗的前3个月每两周监测一次。此后每月监测一次"}, {"probability": {"variance": 0.010541, "average": 0.962606, "min": 0.416135}, "location": {"width": 828, "top": 669, "height": 29, "left": 226}, "words": "对接受本品治疗前或治疗期间出现低钾血症的患者,应注意维持患者的血钾水平不低于"}, {"probability": {"variance": 0.025837, "average": 0.828954, "min": 0.575197}, "location": {"width": 68, "top": 721, "height": 20, "left": 188}, "words": "4.0mM"}, {"probability": {"variance": 0.029758, "average": 0.750886, "min": 0.596108}, "location": {"width": 158, "top": 696, "height": 60, "left": 766}, "words": "能医药"}, {"probability": {"variance": 0.014902, "average": 0.946136, "min": 0.488033}, "location": {"width": 831, "top": 762, "height": 29, "left": 227}, "words": "如果患者发生3级及3级以上毒性事件,包括高血压、低钾血症、永肿或其他非盐皮质激"}, {"probability": {"variance": 0.000699, "average": 0.990438, "min": 0.862268}, "location": {"width": 849, "top": 807, "height": 29, "left": 186}, "words": "素毒性事件,则应停止治疗,并进行适当的医学处理。直到毒性症状缓解至1级或基线水平"}, {"probability": {"variance": 6.2e-05, "average": 0.994417, "min": 0.974764}, "location": {"width": 260, "top": 855, "height": 27, "left": 185}, "words": "方可重新开始使用本品治疗"}, {"probability": {"variance": 0.001074, "average": 0.985432, "min": 0.838483}, "location": {"width": 742, "top": 899, "height": 29, "left": 229}, "words": "如果患者出现漏服本品泼尼松或泼尼松龙,应以常规剂量于次日重新开始治疗"}, {"probability": {"variance": 0.000155, "average": 0.992237, "min": 0.953538}, "location": {"width": 409, "top": 992, "height": 29, "left": 188}, "words": "肝功能损害和肝毒性情况下的剂量调整原则"}, {"probability": {"variance": 0.000112, "average": 0.990114, "min": 0.975155}, "location": {"width": 111, "top": 1038, "height": 29, "left": 190}, "words": "肝功能损害"}, {"probability": {"variance": 0, "average": 0.669472, "min": 0.669472}, "location": {"width": 86, "top": 1038, "height": 50, "left": 987}, "words": " TSSEN"}, {"probability": {"variance": 0.003456, "average": 0.981539, "min": 0.735213}, "location": {"width": 406, "top": 1085, "height": 27, "left": 233}, "words": "基线轻度肝功能损害的患者不需要调整剂量"}, {"probability": {"variance": 0.063778, "average": 0.736458, "min": 0.393988}, "location": {"width": 147, "top": 1077, "height": 66, "left": 947}, "words": "杨森游"}, {"probability": {"variance": 0.002204, "average": 0.970192, "min": 0.806638}, "location": {"width": 928, "top": 1116, "height": 51, "left": 232}, "words": "对于基线中度肝功能损害( child-pugh B级)的患者,本品的推荐剂量应降低至g每"}, {"probability": {"variance": 0.026512, "average": 0.926529, "min": 0.174869}, "location": {"width": 956, "top": 1172, "height": 51, "left": 190}, "words": "天一次。一项在基线中度肝功能损害 child-pugh B级)患者中开展药代动力学研究显示,在单A"}, {"probability": {"variance": 0.006781, "average": 0.966248, "min": 0.559639}, "location": {"width": 744, "top": 1222, "height": 30, "left": 193}, "words": "次口服给药100mg本品后,阿比特龙全身暴露量增加约4倍(见药代动力学)"}, {"probability": {"variance": 0.008999, "average": 0.954969, "min": 0.522381}, "location": {"width": 826, "top": 1269, "height": 30, "left": 237}, "words": "预计在中度肝功能损害患者中,250mg每日1次给药与接受1000mg每日1次的肝功能"}, {"probability": {"variance": 0.004645, "average": 0.972521, "min": 0.671187}, "location": {"width": 869, "top": 1316, "height": 28, "left": 194}, "words": "正常患者中观察到的药时曲线下面积(AUC)相似。但尚无在中度肝功能损害患者中250mg每"}, {"probability": {"variance": 0.00292, "average": 0.973075, "min": 0.752051}, "location": {"width": 867, "top": 1362, "height": 28, "left": 197}, "words": "日1次给药的临床数据,故建议谨慎评估获益风险后方可使用。对于中度肝功能损害患者,开"}, {"probability": {"variance": 0.000991, "average": 0.987186, "min": 0.810646}, "location": {"width": 846, "top": 1409, "height": 27, "left": 196}, "words": "始治疗前、第1个月每周、随后2个月每2、以及之后的每个月应对丙氨酸转氨酶(ALT)"}, {"probability": {"variance": 0.013567, "average": 0.948247, "min": 0.53497}, "location": {"width": 868, "top": 1454, "height": 28, "left": 197}, "words": "天冬氨酶转氨酶(AST).和胆红素水平进行蓝测。如果基线中度肝功能损害惠者的ALT和/或"}], "language": 3}